Work

The direct PAK1 inhibitor, TAT-PAK18, blocks preferentially the growth of human ovarian cancer cell lines in which PAK1 is abnormally activated by autophosphorylation at Thr 423.

FWCI: 0.521
Cites: 16
Cited by: 34
Related to: 10